Background and Purpose-Intracerebral hemorrhage (ICH) has a poorer prognosis than acute ischemic stroke (AIS).
I
ntracerebral hemorrhage (ICH) has a poorer prognosis than acute ischemic stroke (AIS). One-month mortality after ICH is estimated to be ≈40%, around 4× that which is seen in AIS. [1] [2] [3] Long-term outcomes are comparably poor: survival after ICH is 46% at 1 year, with 75% either deceased or severely disabled. 4 A negative perception of prognosis may, however, impact significantly on the management of patients with ICH. Clinical underestimation of the chances of favorable outcome in severe ICH cases may prompt clinicians to limit intensive management strategies 5, 6 and lead to early implementation of endof-life protocols, with the inevitable consequence of higher mortality among these patients. 7 Prognosis may, therefore, be biased as a consequence of clinical perception. However, clinician assessment of prognosis has been shown to more closely predict 3-month outcome ICH than prognostic scales. 8 Despite the differences in outcomes between ICH and AIS, previous studies have reported that stroke type did not influence prognosis when lesion volume and initial severity of symptoms were accounted for. 9 Greater average lesion volume in ICH compared with AIS may determine greater stroke severity in ICH and thus prognosis. 10 More recent registry data reinforce the average greater severity of ICH compared with AIS and suggest association of poorer prognosis to be independent of stroke type. 11 However, these comparisons may be similarly confounded by potential clinical bias in management strategies.
We hypothesized that clinicians would exhibit negative perceptions of ICH compared with AIS by overestimating the volume of brain lesions, assigning greater clinical severity and predicting poorer outcome based on acute CT appearances. 2009 and September 2013. Oral anticoagulant-associated ICH cases were excluded. Ethical approval for the studies was given by national ethics committees and included participant consent for further imaging-based research using deidentified scans. The data that support the findings of this study are available from the corresponding author on reasonable request.
Group Characteristics
Clinical, demographic, and stroke presentation characteristics were recorded for each participant. These included age, sex, medical history, and admission National Institutes of Health Stroke Scale (NIHSS) and estimated prestroke modified Rankin Scale (mRS) scores.
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Image Analysis
Whole brain noncontrast CT scans were acquired using either a Philips Brilliance 64 slice scanner (120 kV; slice thickness, 0.6 mm) or a General Electric optima scanner (120 kV; slice thickness, 0.6 mm). Scans for the ICH cases were acquired <6 hours after onset of symptoms. AIS cases were also recruited <6 hours after symptom onset, but follow-up imaging performed at ≈24 hours was used for comparison in this study to ensure sufficient time had passed to allow adequate visualization of the final infarct. Scans were reviewed for presence or absence of intraventricular extension and ICH location (lobar or deep). ICH volumes were calculated by 2 techniques; the ABC/2 method 14, 15 using manual measurement of maximal ICH diameter in 3 perpendicular x, y, and z planes on a 5-mm thick slice of a multiplanar whole brain noncontrast CT image. Because the ABC/2 method assumes approximately ovoid geometry and may not estimate volume of irregularly shaped ICH accurately, we additionally undertook volumetric analysis using the imaging package MIStar (version 3.2.63) by manually placing a seed region of interest in the hemorrhage on a single axial 5-mm slice, followed by growing the region of interest using automated thresholding and then summation of multiple axial frames to derive a volume.
For each scan, a single observer calculated lesion volumes twice, with a minimum interval of 2 weeks between the first and second measurements. The observer was blinded to first measurements at the time of second measurement. The mean of the 2 measurements was used as the lesion volume. Each of the ICH cases was matched with an AIS scan selected to be within ±10% of the volume of the ICH scan. Infarct volumes for the AIS comparators had been previously calculated using the same MIStar imaging package.
Scan Review
Scans were presented with no accompanying clinical information in a random order to clinicians of different levels of experience. Participants were asked to (1) estimate lesion volume to the nearest 5 mL; (2) give a subjective impression of expected clinical severity on a scale of 1 to 5 (1, mild; 5, very severe); and (3) estimate 30-day prognosis by mRS (0-6).
Statistical Analysis
Statistical analyses were performed using IBM SPSS Statistics, version 21.0. Categorical variables are presented as frequencies and proportions and were compared using Pearson χ 2 test for association and Fisher exact tests. Continuous variables are described as either mean (±SD) or median (interquartile range [IQR] ) and compared using independent samples t test or Mann-Whitney U tests for normally and nonnormally distributed data, respectively. Binary logistic regression analysis was carried out to assess factors (including stroke type, lesion volume, observer experience, and patient age) predicting estimated favorable prognostic outcome (defined by mRS of 0-2).
Results
Study Participants and Cohort Characteristics
Thirty-three CT scans were obtained for analysis as the ICH group and were matched to 33 AIS comparator CT scans from a local research imaging database. Comparison of clinical characteristics for the 2 groups (Table) 
Scan Review
A median of 8 (IQR, 8-8.25 ) observers reviewed each scan. Forty-eight percent (n=16) of observers were experienced (14 stroke physicians and 2 neurologists) and 17 less experienced (5 senior medical trainees, 7 junior medical trainees, 4 clinical research fellows, and 1 stroke research nurse specialist).
A median of 6 (IQR, 5-7) volume estimations were made per scan. Thirteen scans from both the ICH and the AIS groups had ≤5 volume estimates. Mean measured lesion volume was the same for both groups: 25±30 mL for the ICH 
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group and 26±32 mL for the AIS group ( Figure 1 ). Mean estimated lesion volume for ICH cases was significantly greater than for AIS cases (32±33 compared with 17±23 mL, respectively; P<0.001). The mean difference between estimated and actual lesion volume was +8 mL (±30) for the ICH group and −8 mL (±27) for the AIS group (P<0.001; Figure 2) . A sensitivity analysis found that there was no difference in volumes between scans that had ≤5 volume estimates when compared with scans with >5. There were 265 estimates of clinical severity and 30-day prognosis for the ICH group and 257 for the AIS group. Clinicians graded ICH to be of greater severity than AIS (Figure 3) with estimates of the greatest severity (categories 4 or 5) in 41% (n=109) of ICH case estimates compared with 14% (n=36) for AIS cases (P<0.001). Clinicians also estimated ICH cases to have less likelihood of favorable 30-day prognosis (defined as mRS of 0-2), predicting independent recovery in 47% (n=125) of ICH cases compared with 74% (n=190) of AIS cases (Figure 4 ; P<0.001). Differences remained statistically significant for both analyses after omitting observers who did not make volume estimations.
In binary logistic regression, significant univariate predictors of estimated favorable outcome (mRS 0-2) were stroke type (ICH compared with AIS; odds ratio [ In exploratory analyses, we assessed whether radiological features that might have influenced observers modified the association of stroke type with estimated prognosis. Intraventricular hemorrhage (IVH) was present in 11 of 33 ICH cases (33%) but did not significantly influence estimated lesion volume or predicted outcome. Differences in volume estimations between AIS and ICH groups remained statistically significant after excluding cases with IVH. Presence of IVH was unrelated to either actual or estimated parenchymal ICH volumes: comparing presence and absence of IVH cases, measured parenchymal ICH volumes were 22 and 27 mL, respectively (P=0.174), and estimated ICH volumes 30 and 34 mL (P=0.498). Forty-three percent (n=31) of IVH positive cases were predicted to have mRS of 0 to 2 compared with 48% (n=93) of IVH-negative cases (P=0.480). Median midline shift was 2.5 mm in both ICH and AIS groups (Mann-Whitney U test; P=0.658). Ventricular effacement of any degree was more commonly seen in ICH cases: 19 of 33 cases versus 10 of 33 (OR, 3.12; 95% CI, 1.13-8.60). Both midline shift and ventricular effacement were each associated with poorer estimated mRS outcomes. In a logistic regression analysis that included midline shift and ventricular effacement, stroke type remained significantly associated with reduced odds of favorable estimated 30-day mRS (OR, 0.44; 95% CI, 0.29-0.67; P<0.001).
There were 13 deep/basal ganglionic and 20 lobar ICH cases. Deep/basal ganglionic ICHs were smaller than lobar ICH (17 compared with 36 mL; P<0.001). Estimated lesion volumes for both deep/basal ganglionic bleeds and lobar bleeds were significantly greater than measured volumes (22 and 46 mL, respectively; P<0.001 for each). Sixty percent (n=86) of deep/basal ganglionic bleeds were estimated to have a favorable 30-day prognosis compared with 31% (n=38) of lobar ICH cases (P<0.001).
Discussion
Using CT scans matched for lesion volume, we found that clinicians significantly overestimated the volume of ICH and underestimated the volume of AIS. In addition, clinicians estimated clinical severity to be significantly greater for ICH and predicted less likelihood of favorable 30-day outcomes for ICH compared with AIS, even after adjusting for estimated lesion volume and independent of radiological features including midline shift, and ventricular effacement.
IVH is associated with greater ICH severity [16] [17] [18] and was present in a third of our ICH cases but did not seem to influence clinicians' interpretation of volume, severity, or prognosis.
Limitations of this study include its small sample size and its single-center, retrospective design. We did not match cases for imaging features denoting brain frailty, such as the presence of brain atrophy, established cerebrovascular lesions, or small vessel disease 19, 20 that may have impacted clinicians' estimates; however, patient age (as a surrogate for brain frailty measures) did not modify the significant differences between ICH and AIS in estimated prognosis. Although we selected control cases on the basis of lesion volume, location may also be relevant to both prognosis and severity and was not matched across the study groups. 21, 22 Similarly, we were not able to account for other factors of prognostic relevance, such as hematoma location, IVH, hematoma density, and morphology, [23] [24] [25] [26] [27] which often have no correlate in AIS cases. Additionally, a single baseline CT cannot capture the dynamic nature of ICH, the hematoma expansion commonly seen in the early hours after onset signifying poorer prognosis. [28] [29] [30] A greater propensity for deep location of ICH compared with AIS with internal capsular involvement could have accounted for the higher median NIHSS scores in ICH cases because motor function represents a higher proportion of scores than other aspects of neurological deficit. 12 Level of consciousness accounted for only a small proportion of total NIHSS score in both groups. It is possible that observers may have taken lesion location into account when making prognostic estimations, but this could not be included in our analysis because the inherently different pathologies make matching of both volume and location for ICH cases with equivalent AIS cases extremely challenging. Lobar hemorrhages were estimated to have poorer 30-day prognosis compared with deep/basal ganglionic ICH, but lobar ICHs were significantly larger; therefore, volume is likely to be the dominant factor considered by clinicians. 
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Our results suggest that a bias is present among clinicians in assessing stroke severity and prognosis for ICH compared with AIS. This may be of importance because outcomes are significantly affected by acute management, including end-oflife decisions or delays in secondary preventative treatment or rehabilitation.
31-33
Disclosures
None.
